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Background The EUropean Project on obstetric Haemorrhage
Reduction: Attitudes, Trial, and Early warning System
(EUPHRATES) is a set of five linked projects, the first component
of which was a survey of policies for management of the third
stage of labour and immediate management of postpartum
haemorrhage following vaginal birth in Europe.
Objectives The objectives were to ascertain and compare policies
for management of the third stage of labour and immediate
management of postpartum haemorrhage in maternity units in
Europe following vaginal birth.
Design Survey of policies.
Setting The project was a European collaboration, with
participants in 14 European countries.
Sample All maternity units in 12 countries and in selected regions
of two countries in Europe.
Methods A postal questionnaire was sent to all or a defined
sample of maternity units in each participating country.
Main outcome measures Stated policies for management of the
third stage of labour and the immediate management of
postpartum haemorrhage.
Results Policies of using uterotonics for the management of the
third stage were widespread, but policies about agents, timing,
clamping and cutting the umbilical cord and the use of controlled
cord traction differed widely. For immediate management of
postpartum haemorrhage, policies of massaging the uterus were
widespread. Policies of catheterising the bladder, bimanual
compression and in the choice of drugs administered were much
more variable.
Conclusions Considerable variations were observed between and
within countries in policies for management of the third stage of
labour. Variations were observed, but to a lesser extent, in policies
for the immediate management of postpartum haemorrhage after
vaginal birth. In both cases, policies about the pharmacological
agents to be used varied widely.
Keywords Management policies, obstetric emergencies,
postpartum haemorrhage, third stage of labour.
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Intrapartum care
Introduction
Despite the overall decline in maternal mortality in high-income
countries, including those in Europe, since the middle of the 20th
century, postpartum haemorrhage still makes a major contribution
to maternal mortality and severe maternal morbidity in Europe.1–3
A collaborative project in the mid-1990s showed that there
were wide differences between rates of severe pre-eclampsia,
sepsis and postpartum haemorrhage in participating Euro-
pean countries, even though common definitions were used
to collect the data.1 In this survey, overall differences between
countries were dominated by differences in the incidence
of postpartum haemorrhage. This ranged from 8.8 per 1000
deliveries in Finland to 0.7 in Austria. Possible explanations
included differences in ascertainment,1 differences in the age
distribution of women giving birth3 and differences in the
ways in which care is provided and its quality.4
There is a prevailing view that the quality of care is partic-
ularly crucial where postpartum haemorrhage is concerned and
that substandard care contributes to differences in the inci-
dence of postpartum haemorrhage. Therefore, the adoption
of appropriate policies, the availability of sufficient resources
and the deployment of these resources to provide good care are
central to the reduction of rates of severe postpartum haemor-
rhage.4 Despite this, little is known about relevant policies or
practices in Europe. In response to these concerns, the five-part
EUropean Project on obstetric Haemorrhage Reduction: Atti-
tudes, Trial, and Early Warning System (EUPHRATES) was
undertaken to address issues related to the prevention and
management of postpartum haemorrhage.
The first component of this project was a survey undertaken
to describe current obstetric and midwifery policies related to
the prevention and management of postpartum haemorrhage
in 14 countries of Europe and to inform the second part of the
project, the development of a minimal European consensus
for good practice related to the prevention and management of
obstetric postpartum haemorrhage.5 The survey covered hos-
pital policies in all the 14 countries and home birth policies
in two of them. This article describes the methods used and
the key findings about policies for the management of the
third stage of labour and the immediate management of severe
postpartum haemorrhage after vaginal birth in hospital and
compares them with the available evidence.
Methods
The project was a European collaboration, with participants
from 12 European Union member states, Austria, Belgium,
Denmark, Finland, France, Hungary, Ireland, Italy, the
Netherlands, Portugal, Spain, and the UK plus Norway and
Switzerland. Most countries sent a questionnaire to all their
maternity units. The exceptions were Spain, where the survey
covered maternity units in Catalonia; Portugal, where private
maternity units were not surveyed; and France, where a pur-
posive sample of six regions, reflecting a range of measures of
maternal health and diversity of maternity care provision, was
selected from regions willing to participate. Country coordi-
nators were asked to provide available information about the
units surveyed to enable the investigation of possible response
bias in countries with low response rates.
A postal questionnaire was designed by the study steering
group and refined and piloted by each participating country. It
was sent out in 2003 and included questions about definition of
postpartum haemorrhage, policies for management of the third
stage of labour in vaginal birth and caesarean section, measure-
ment of blood loss and management of postpartum haemor-
rhage. In each case, respondents were asked whether the policy
in their unit was to use the specified interventions usually, occa-
sionally, sometimes or never. In addition, questions were asked
about the resources available in each maternity unit and about
the level of activity in the preceding year, 2002.
The questionnaire was initially developed in English, and
collaborators in each country decided whether translation
into local languages would be beneficial. As a result, colla-
borators in France, Hungary, Norway, Portugal, Italy and
Spain translated the questionnaire into their own languages.
In Spain, where the survey was undertaken in Catalonia, the
questionnaire was translated into both Catalan and Spanish
languages, giving respondents a choice of language in which
to reply. Because of the highly technical nature of the ques-
tions, formal back translation was not undertaken, but the
questionnaires were checked against the English original.
Coordinators in each participating country established or
obtained a list of maternity units to be surveyed. One ques-
tionnaire was sent to each unit, addressed to the midwife or
obstetrician with overall management responsibility. Details
are shown in Table 1. Two reminders were sent to non-
respondents, and additional prompts were given in some
countries. The questionnaires were returned to coordinators
within the country and then forwarded to City University,
London, where data were entered onto an Access database
and checks for inconsistency were undertaken. If any issues
in the questionnaires needed clarification, the country coor-
dinators were contacted for an explanation. The data were then
analysed using the Statistical Package for the Social Sciences,
version 12.0 for Windows (SPSS Inc., Chicago, IL, USA).
This article describes the replies to five questions about the
management of the third stage of labour and five questions
about the immediate management of postpartum haemor-
rhage following vaginal birth.
The third stage of labour is defined as the period from birth
of the baby until the placenta and its membranes are expelled.
A sequence of procedures, known as ‘active management’, has
been developed, but there is considerable variation in how
these policies are defined and practised. As part of its consen-
sus development process, the EUPHRATES group defined
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‘active management’ as an intervention with the following
three components:
1. Prophylactic administration of a uterotonic agent.
2. Clamping and cutting the cord immediately after birth or
after it has stopped pulsating.
3. Controlled cord traction to aid the delivery of the placenta.
The analysis first looked separately at each component of
active management and then at the extent to which respond-
ing units said that they used them all.
The questions about management of the third stage asked
about policies for clamping and cutting the umbilical cord,
draining the placenta, controlled cord traction and the pro-
phylactic use of uterotonics, including their type and the
timing of administration. In each case, the question asked
whether the practice was used ‘usually’, ‘sometimes’, ‘rarely’
or ‘never’. If there was no reply to the question, this was
interpreted as implying that there was no policy about using
the practice.
Tables 2–4 are based on numbers of units in which the various
interventions were said to be used ‘usually’, as this was assumed
to imply either formally adopted or informally accepted policies.
Where respondents replied ‘usually’ to two apparently mutually
exclusive practices, this was tabulated separately.
The questions about the immediate management also
asked whether the practices were used ‘usually’, ‘sometimes’,
‘rarely’ or ‘never’ and were analysed in the same way. The
questions about use of pharmacological or other agents for
the immediate management of haemorrhage asked respond-
ents to name the agent which would be used first and which
would be used next if bleeding continued.
The responses were compared using both asymptotic and
Monte Carlo estimates of Pearson’s chi-square, calculated
using StatXact.7 (Cytel Inc., Cambridge, MA, USA). The results
were compared with the evidence available from Cochrane
reviews, summarised in Figure 1.
Role of the funding source
The project was funded by the European Union under Frame-
work 5. The sponsor of the study had no role in study design,
data collection, data analysis, data interpretation or the writ-
ing of the report. The steering group had full access to all the
data in the study and had final responsibility for submission
for publication on behalf of the EUPHRATES Group.
Results
Response rates and investigation of response bias
The number of questionnaires sent out ranged from 22 in Ire-
land to 719 in Italy. This wide range resulted from differences
in the overall numbers of births and in the sizes of maternity
units in the participating countries. Response rates varied from
29.9% in Italy and 31.7% in Austria to 100% in Hungary,
Finland and Ireland, with response rates above 65% in 11
out of 14 countries, as Table 1 shows, with only Austria, Italy
and Switzerland having rates below this level. In Italy, response
rates in public and private hospitals were similar. Among pub-
lic hospitals, for which fuller information was available, there
was considerable regional variation, with rates around 50% in
the regions of Lombardia, Veneto and Friuli-Venezia Giulia.
Elsewhere, response rates ranged from zero among the nine
maternity units in Umbria to around 40% in the regions of
Puglia and Basilicata. In Switzerland, response rates were
higher from the public sector than from the private sector, with
only a few private hospitals replying. No information was avail-
able to investigate possible response bias in Austria.
Table 1. Samples and response rates
Country Maternity
units sampled
Language Number of
units surveyed
Number of
questionnaires received
Response
rate (%)
Austria All English 104 33 31.7
Belgium All English 129 105 81.4
Denmark All English 29 23 79.3
Finland All English 33 33 100.0
France Six regions French 132 109 82.6
Hungary All Hungarian 98 98 100.0
Ireland All English 22 22 100.0
Italy All Italian 719 215 29.9
Netherlands All English 99 91 91.9
Norway All Norwegian 55 46 83.6
Portugal All public maternity units Portuguese 52 37 71.2
Spain Catalonia Catalan and Spanish 62 53 85.5
Switzerland All English 130 68 52.3
UK All English 354 242 68.4
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In the statistical tests undertaken on the data in Tables 1–5,
P values were below 0.0005 in each case, demonstrating wide
differences in policies between the participating countries.
Managing the third stage of labour
Cutting and clamping the cord and draining the placenta
Maternity units were asked about the point at which the cord
was clamped and cut. Table 2 shows that between 66 and 90%
of units in Belgium, France, Ireland, Italy, the Netherlands,
Portugal, Spain, Switzerland and the UK had policies of
clamping and cutting the cord immediately after the birth,
but between 65 and 74% of units in Austria, Denmark,
Finland, Hungary and Norway had policies of waiting until
the cord stopped pulsating. More than 10% of units in
Austria, Hungary, Italy and Switzerland did not give a stated
policy. Five units, three in the UK, one in Spain and one in
Norway, said they usually cut the cord at both times and were
included in those with no stated policies.
Replies to the question about draining the placenta, which
is not seen as part of ‘active management’, suggested that this
practice was not widespread in any country, except in
Belgium, where it was policy in 32% of maternity units, and
Portugal, where it was a policy in 24%. Apart from this, it
was policy in approximately 14% of units in Ireland, 15% of
units in Norway and Spain and between 0 and 7% in the other
countries, as Table 2 shows.
Controlled cord traction
Policies of controlled cord traction were also common, but
their extent differed markedly between countries. Controlled
cord traction was policy in 87% of units in the UK, in 95% of
those in Ireland and from 39 to 51% of units in Belgium, the
Netherlands, Norway, Portugal and Switzerland. In the other
participating countries, it was said to be policy in between 12
and 25% of units.
Prophylactic use of uterotonics
It was policy to use uterotonics prophylactically in between 72
and 100% of units in most participating countries apart from
Austria and Denmark where 55 and 57% of the units, respec-
tively, reported a policy of using them, as Table 2 shows.
Policies for the timing of prophylactic administration of
uterotonics diverged considerably, as Table 3 shows. In the
68% of units in the UK and Ireland, it was policy to admin-
ister them immediately after the delivery of the anterior
shoulder, while between 62 and 87% of units in Denmark,
Finland, the Netherlands, Norway and Switzerland favoured
administering uterotonics immediately after birth. Between
69 and 77% of units in Italy, Portugal and Spain had policies
of administering them after the delivery of the placenta. In
Belgium, France and Hungary, policies differed both between
and within units. In particular, 10% of units in Belgium and
19% in France cited more than one policy. It is possible that,
in these units, two doses of uterotonic are administered at
Table 2. Policies for management of the third stage of labour after vaginal birth in maternity units from 14 European countries
All units
replying,
n
Timing of cutting and clamping cord Controlled
cord traction,
n (%)
Administration
of prophylactic
uterotonics,
n (%)
Active
management,**
n (%)
Draining
the placenta,
n (%)Immediately
after birth,
n (%)
After the cord
stops pulsating,
n (%)
Other and
not stated,*
n (%)
Austria 33 5 (15) 23 (70) 5 (15) 7 (21) 18 (55) 1 (3) 1 (3)
Belgium 105 92 (88) 11 (10) 2 (2) 45 (43) 93 (89) 36 (34) 34 (32)
Denmark 23 4 (17) 17 (74) 2 (9) 5 (22) 13 (57) 2 (9) 1 (4)
Finland 33 9 (27) 23 (70) 1 (3) 7 (21) 29 (88) 4 (12) 2 (6)
France 109 98 (90) 7 (6) 4 (4) 24 (22) 104 (95) 22 (20) 7 (6)
Hungary 98 20 (20) 66 (67) 12 (12) 12 (12) 89 (91) 5 (5) 3 (3)
Ireland 22 16 (73) 5 (23) 1 (5) 21 (95) 22 (100) 17 (77) 3 (14)
Italy 215 142 (66) 43 (20) 30 (14) 28 (13) 197 (92) 20 (9) 14 (7)
Netherlands 91 67 (74) 21 (23) 3 (3) 41 (45) 86 (95) 33 (36) 0 (0)
Norway 46 11 (24) 30 (65) 5 (11) 18 (39) 33 (72) 5 (11) 7 (15)
Portugal 37 33 (89) 1 (3) 3 (8) 19 (51) 31 (84) 13 (35) 9 (24)
Spain 53 40 (75) 7 (13) 6 (11) 13 (25) 45 (85) 7 (13) 8 (15)
Switzerland 68 47 (69) 10 (15) 11 (16) 31 (46) 60 (88) 25 (37) 2 (3)
UK 242 186 (77) 31 (13) 25 (10) 210 (87) 232 (96) 182 (75) 8 (3)
*A few units had more than one ‘usual’ policy or had a policy of cutting the cord ‘at another time’.
**Usually cut the cord immediately after birth or after the cord stops pulsating, perform ‘controlled cord traction’ and administer
prophylactic uterotonics.
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different stages, with the first dose being administered either
at the delivery of the anterior shoulder or immediately after
the birth and the second after the expulsion of the placenta.
In units with a policy of administering prophylactic utero-
tonics, the agent most commonly used was oxytocin alone.
This was used in more than 90% of units in France, the
Netherlands, Norway, Portugal, Spain and Switzerland. The
exception was in the UK and Ireland, where Syntometrine,
a fixed combination of oxytocin and ergometrine, was used in
87 and 64% of units, respectively. This formulation is not
licensed for use in any other participating countries, possibly
apart from Austria. Of the seven units in Italy reporting using
it, one had used it experimentally and the others had used
combinations of oxytocin and ergometrine separately. This
also could have been the case in the units in Denmark and
Austria, which reported using it prophylactically.
Much smaller proportions of units, ranging from 14 to
26%, in Belgium, Finland and Italy had policies of using only
ergometrine. In addition, in these countries plus Hungary and
Austria, between 12 and 35% of units said they used more
than one type of prophylactic uterotonic, the usual combina-
tion being oxytocin and ergometrine. In France, the coordi-
nator reported that some of these replies arise from policies of
using ergometrine after the placenta is delivered, having used
oxytocin at an earlier stage.
Active management
The proportions of units with policies of using the full pack-
age of active management of the third stage of labour
described earlier were much lower. While 77% of units in
Ireland and 75% of those in the UK had a set of policies which
fitted the definition of active management, only 34–37% of
units in Belgium, the Netherlands, Portugal and Switzerland
and fewer than 20% of those in the other participating coun-
tries had policies of active management, as Table 2 shows. It
this case, units which answered ‘usually’ to both timings for
cutting and clamping the cord were included.
Procedures for immediate management of
postpartum haemorrhage
From 82 to 100% of units in every country had a policy of
massaging the uterus on occasions when postpartum haemor-
rhage occurs, as Table 4 shows. The proportion of units in
each country which had a policy of catheterising the bladder
was 80% or more in Austria, France, Hungary, Ireland, the
Netherlands and the UK. It ranged from 55 to 75% in
Belgium, Italy, Norway, Portugal, Spain and Switzerland. In
contrast, only 39% of units in Denmark and 27% in Finland
reported this policy. Between 34 and 68% of units in all coun-
tries had policies of using bimanual compression of the uterus.
The exceptions were in the Netherlands and Italy, where only 15
and 21% of maternity units, respectively, reported this policy.
Administration of pharmacological agents
There were considerable differences both between and within
countries in their choice of drugs for the immediate manage-
ment of postpartum haemorrhage. The proportion of all units
using oxytocin alone as their first choice ranged from 28% in
the UK to 95% in Portugal. This included 80–95% of the units
in France, Hungary, Italy, Norway and Portugal, as Table 5
shows. Syntometrine was used as a drug of first choice in
18% of units in the UK and 41% of those in Ireland but was
used in only one unit in each of Austria, Finland and Switzer-
land. As Syntometrine is not licensed for use in these coun-
tries, possibly except in Austria, it could be that these units
had a policy of using oxytocin and ergometrine in combina-
tion. Slightly more than 40% of the units in UK and Spain
reported using ergometrine alone as first line management.
About one-fifth of units in Austria, Belgium and the Nether-
lands had policies of using injectable prostaglandins, while
22% of units in Denmark, 18% of those in Finland and
15% in France had a policy of using misoprostol.
There was similar diversity in the drug of second choice,
should the postpartum haemorrhage not be controlled with
the first. In Belgium, France, Hungary, Italy, the Netherlands
and Portugal, prostaglandins were the agent of second choice
in 50–80% of units. Ergometrine alone was the second choice
in more than two-fifths of units in Austria and Spain. Only
units in the UK and Ireland gave oxytocin alone as their
second choice. This was the case for 46% of units in the UK
and 32% of those in Ireland. Only 306 units, just more than
one-quarter, specified a third choice of drug, and 259 of these
specified either injectable prostaglandins or misoprostol.
Table 4. Policies about use of mechanical methods for controlling
postpartum haemorrhage in maternity units from 14 European
countries
Country All
units
replying,
n
Massage
the
uterus,
n (%)
Catheterise
the
bladder,
n (%)
Bimanual
compression
of uterus,
n (%)
Austria 33 29 (88) 27 (82) 16 (48)
Belgium 105 100 (95) 79 (75) 44 (42)
Denmark 23 22 (96) 9 (39) 13 (57)
Finland 33 30 (91) 9 (27) 14 (42)
France 109 98 (90) 87 (80) 40 (37)
Hungary 98 82 (84) 82 (84) 35 (36)
Ireland 22 22 (100) 21 (95) 8 (36)
Italy 215 201 (93) 118 (55) 45 (21)
Netherlands 91 75 (82) 84 (92) 14 (15)
Norway 46 42 (91) 29 (63) 21 (46)
Portugal 37 37 (100) 26 (70) 25 (68)
Spain 53 52 (98) 36 (68) 21 (40)
Switzerland 68 58 (85) 49 (72) 31 (46)
UK 242 229 (95) 229 (95) 82 (34)
Winter et al.
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Draining the placenta
Packages for the active
management of third
stage of labour which
did and did not include
placental cord
drainage
12
477 women and 147
women
Cochrane review
of two trials
It is difficult to draw any major conclusions from the identified
research studies, due to the small numbers, poor quality and
varied format of reporting, although a statistically significant
reduction in the length of the third stage of labour was observed
when performing cord drainage.
Immediate management of haemorrhage
Massaging  the uterus
Catheterising the
bladder
Bimanual compression
Drugs of first and
second choice 
None, apart from physiological observation of effect
None, apart from weak physiological observation 
None, apart from weak physiological observation
13
14 64 women with
postpartum
haemorrhage over
500 ml in two centres.
Cochrane review
but only one
eligible trial
Rectal misoprostol in a dose of 800 micrograms could be a
useful 'first line' drug for the treatment of primary postpartum
haemorrhage but more research is needed.
8
34203 women Cochrane review
of 24 trials of
misoprostol and 8
trials of
intramuscular
prostaglandin
Neither intramuscular prostaglandins nor misoprostol are
preferable to conventional injectable uterotonics as part of the
active management of the third stage of labour especially for
low-risk women.
Clamping the cord
Early cord clamping
with late cord
clamping
9
Not yet published Protocol for
Cochrane review
The objective is to determine the maternal and neonatal effects
of different strategies for the timing of clamping the cord of term
babies.
Timing of prophylactic oxytocin administration
Administration of
prophylactic oxytocin
before and after
delivery of the
placenta
Administration of
prophylactic oxytocin
before and after
delivery of the
placenta 
10
51 women with
singleton pregnancies
Double-blinded
randomised trial
Postpartum haemorrhage was less frequent when oxytocin
administration was delayed until after placenta delivery.
11
1486 women Randomised trial The administration of prophylactic oxytocin before placental
delivery does not reduce the incidence of postpartum
haemorrhage or third-stage duration, when compared with
giving oxytocin after placental delivery. The incidence of
retained placenta was similar in both groups. 
Main comparison Reference
number 
Number of women Study type Results
Management of third stage
Active management as
a package compared
with expectant
management
6477 women Cochrane review
of five
randomised trials,
four of good
quality
Active management of the third stage of labour was more
effective in reducing blood loss after birth than expectant
management, using none of these. 
Prophylactic uterotonics 
Prophylactic
ergometrine–oxytocin
compared with
prophylactic oxytocin
6
9332 women Cochrane review
of six randomised
trials.
Ergometrine–oxytocin appears to be associated with a small but
statistically significant reduction in the risk of postpartum haemorrhage 
when compared with oxytocin for blood loss of 500 ml or more. No
statistically significant difference was observed between the
groups for blood loss of 1000 ml or more. Ergometrine–oxytocin
was more likely to carry adverse effects for the mother compared with
oxytocin.
A. Comparison of
oxytocin with no
uterotonics
B. Comparison of
oxytocin with ergot
alkoloids
C. Comparison of
oxytocin plus
ergometrine with ergot
alkoloids
Randomised or quasi-
randomised trials
comparing a
prostaglandin agent
with another
uterotonic or no
prophylactic
uterotonic
7
Over 3000 pregnant
women anticipating a
vaginal delivery
where oxytocin was
given prophylactically
for the third stage of
labour.
Cochrane review
of 14 randomised
or quasi-
randomised
controlled trials.
Oxytocin appears to be beneficial for the prevention of
postpartum haemorrhage. There is insufficient information about
other outcomes and adverse effects so it is difficult to be confident
about the trade-offs for these benefits. There seems little
evidence in favour of ergot alkaloids alone compared with either
oxytocin alone or with ergometrine-oxytocin, but the data are
sparse.
Figure 1. Summary of Cochrane reviews and other evidence.
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Discussion
This survey showed considerable differences both between
countries and between maternity units within European
countries in their stated policies for management of the third
stage of labour and the immediate management of post-
partum haemorrhage. Countries were used as sampling units,
both for administrative reasons and also because it was
thought that national professional organisations would be
likely to issue guidelines and policy recommendations to their
members. In fact, only Hungary, the Netherlands, Norway,
Spain and Scotland had guidelines on the subject at the time
the survey was undertaken, although guidelines have been
published subsequently in Denmark and France. The status
and influence of these guidelines and the professional and
other organisations issuing them is known to vary between
countries. For these reasons, one of the components of this
project was the development of a consensus statement.5
Because the study included countries where collaborators
could be readily identified, it covered 11 of the member states
of the European Union at the time it was undertaken;
Hungary, which has subsequently joined, plus two nonmem-
bers, Switzerland and Norway. In most countries, all mater-
nity units were surveyed. The exceptions were France,
Portugal and Spain. In Portugal, private hospitals were not
surveyed because they usually only rent out facilities for deliv-
eries and have no hospital policies on clinical issues. These
represented about 5.5% of births in the country at the time
the survey was carried out. In France, six regions, containing
about 20% of units in France, were surveyed. They were pur-
posively selected to be representative of different parts of the
country. The units in these regions were compared to all units
in France using data from the 2003 National Perinatal Survey
and found to be representative in terms of unit size and level
of care and status as university, other public or private units.
In Spain, the coordinator chose, for administrative con-
venience, to survey all units in Catalonia. Two countries
had exceptionally low response rates, Italy where, because of
illness on the part of the coordinator, reminders were not
sent out, and Austria.
It has been shown that many maternity units in most coun-
tries do not use the full package of active management but do
use some of its components. Most have policies about cutting
and clamping the cord, either immediately after the birth or as
soon as the cord stops pulsating, but differences in policies
about controlled cord traction are much wider. Policies of
using uterotonics are very widespread, and differences again
relate to the timing of administration together with the
pharmacological agent used.
At first sight, the information in Figure 1 suggests that
Cochrane reviews provide clear evidence about the active
management of the third stage of labour, but closer exami-
nation raises a number of questions. Much of the debate and
research about the management of the third stage of labour is
based on an assumed dichotomy between ‘active’ and ‘expec-
tant’ management. Definitions of active management usually
imply a combination of the use of uterotonics, early cord
clamping and active efforts to deliver the placenta following
delivery, but the definition is neither unambiguous nor
agreed in practice.9
A particularly striking difference was in policies about use
of uterotonics. While in the UK and the Irish Republic most
units had a policy of using Syntometrine, it appears that it
was not available in any of the other participating countries.
There may be a number of reasons for this. For example,
Belgium and Spain have policies of not licensing products
Table 5. Drug of first choice for management of postpartum haemorrhage in maternity units from 14 European countries
Country All units
replying,
n
Oxytocin,
n (%)
Syntometrine,
n (%)
Ergometrine,
n (%)
Injectable
prostaglandins,
n (%)
Misoprostol,
n (%)
Other and
not stated,
n (%)
Austria 33 23 (70) 1 (3) 3 (9) 6 (18) 0 (0) 0 (0)
Belgium 105 56 (53) 0 (0) 29 (28) 18 (18) 0 (0) 0 (0)
Denmark 23 17 (74) 0 (0) 1 (4) 0 (0) 5 (22) 0 (0)
Finland 33 24 (73) 1 (3) 1 (3) 1 (3) 6 (18) 0 (0)
France 109 87 (80) 0 (0) 1 (1) 4 (4) 16 (15) 1 (1)
Hungary 98 80 (82) 0 (0) 6 (6) 11 (11) 1 (1) 0 (0)
Ireland 22 10 (45) 9 (41) 2 (9) 0 (0) 1 (5) 0 (0)
Italy 215 172 (80) 0 (0) 21 (10) 10 (5) 9 (4) 2 (1)
Netherlands 91 51 (56) 0 (0) 19 (21) 19 (21) 2 (2) 0 (0)
Norway 46 39 (85) 0 (0) 2 (4) 1 (2) 4 (9) 0 (0)
Portugal 37 35 (95) 0 (0) 1 (3) 0 (0) 1 (3) 0 (0)
Spain 53 29 (55) 0 (0) 23 (43) 1 (2) 0 (0) 0 (0)
Switzerland 68 41 (60) 1 (1) 13 (19) 4 (6) 8 (12) 1 (1)
UK 242 68 (28) 44 (18) 102 (42) 16 (7) 3 (1) 9 (4)
Winter et al.
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which contain two compounds. As oxytocin and ergometrine
are both available, then it could be argued that Syntometrine
is unnecessary. In addition, the relevant Cochrane review
clearly states that there are more unpleasant adverse effects
with Syntometrine than with oxytocin.7 So this might make
some countries reluctant to license Syntometrine.
Although there have been a considerable number of ran-
domised trials of care in the third stage of labour, most have
either compared the various pharmacological agents used or
compared expectant with active management as a whole.6–9
Very few studies have attempted to examine the relative con-
tribution of the individual components of active manage-
ment. The policy of draining the placenta is not widespread
but has been the subject of a Cochrane review, which iden-
tified only four trials, two of which were excluded on the
grounds of inadequate reporting.13 Thus, there are still major
gaps in the evidence about the optimal management of the
third stage.
The survey showed similarities in policies for the imme-
diate management of postpartum haemorrhage but consid-
erable differences in the choice of pharmacological agents.
Variation in policies for the management of postpartum
haemorrhage was also found in a survey of maternity units
conducted in 2000–01 in the UK.15 Evidence about manage-
ment of postpartum haemorrhage is extremely sparse. No
research has been carried out to establish the usefulness or
efficacy of mechanical methods for the management of post-
partum haemorrhage caused by uterine atony, let alone
about postpartum haemorrhage resulting from tears or rup-
tures. Bimanual compression of the uterus tends to be used
in environments, such as a home birth, where there is no
medical support. It maintains homeostasis until the arrival
of medical help.16,17 A Cochrane review of drugs for imme-
diate management of postpartum haemorrhage identified
just one small trial which suggested that rectal misoprostol
could be a useful first line treatment but that further trials
were needed.14
Since this survey was undertaken, a number of trials of use
of misoprostol, both for the third stage of labour and for the
immediate management of haemorrhage, have been pub-
lished, so this might have led to changes in policies. On the
other hand, a review by the International Confederation of
Midwives and the International Federation of Gynaecology
and Obstetrics has suggested that as far as the management
of the third stage is concerned, the main advantages of miso-
prostol are in resource-poor countries where it is difficult to
maintain oxytocin at the required temperature.18
Despite these limitations, this survey has provided new
information about differences in policies for management
of the third stage of labour and the immediate management
of postpartum haemorrhage in Europe.
This project did not attempt to fill the gap in information
about the relationship between units’ stated policies and their
actual practice. A comparison of actual practice in units with
the same stated policy was undertaken in 1999 in an inter-
national survey. This observed practice in the management of
the third stage of labour in approximately 30 successive vag-
inal deliveries in 15 university-based obstetric centres with
policies of active management of the third stage in two
high-income and 13 low-income countries. It found consid-
erable variations within and between units in the use of active
management.19 This suggests that if there were guidelines for
management, they were not clearly implemented, although
compared with Europe, other issues may be involved, notably
the availability of oxytocic drugs. Nevertheless, the existence
of guidelines can affect practice, especially if practice is
audited.20,21
Conclusions
Considerable differences in policies for managing the third
stage of labour were observed both between and within coun-
tries. For policies which were widespread, notably cutting and
clamping the cord and use of uterotonics, there were differ-
ences in timing and use of pharmacological agents. There
were greater similarities in policies for the immediate man-
agement of postpartum haemorrhage, but considerable differ-
ences between and within countries in the choice of
pharmacological agents. Further research is needed to ascer-
tain whether policies are being translated into practice and
assess their associations with the incidence and consequences
of postpartum haemorrhage.
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